Close

Jefferies Downgrades Bristol-Myers Squibb Co. (BMY) to Hold

October 16, 2017 4:26 AM EDT Send to a Friend
Jefferies downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Hold with a price target of $71.00 (from $72.00).Analyst Jeff ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login